These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36680854)

  • 1. Whole blood transcript and protein abundance of the vascular endothelial growth factor family relate to cognitive performance.
    Libby JB; Seto M; Khan OA; Liu D; Petyuk V; Oliver NC; Choi MJ; Whitaker M; Patterson KL; Arul AB; Gifford KA; Blennow K; Zetterberg H; Dumitrescu L; Robinson RA; Jefferson AL; Hohman TJ
    Neurobiol Aging; 2023 Apr; 124():11-17. PubMed ID: 36680854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain expression of the vascular endothelial growth factor gene family in cognitive aging and alzheimer's disease.
    Mahoney ER; Dumitrescu L; Moore AM; Cambronero FE; De Jager PL; Koran MEI; Petyuk VA; Robinson RAS; Goyal S; Schneider JA; Bennett DA; Jefferson AL; Hohman TJ
    Mol Psychiatry; 2021 Mar; 26(3):888-896. PubMed ID: 31332262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of vascular endothelial growth factor in neurodegeneration and cognitive decline: exploring interactions with biomarkers of Alzheimer disease.
    Hohman TJ; Bell SP; Jefferson AL;
    JAMA Neurol; 2015 May; 72(5):520-9. PubMed ID: 25751166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-omic characterization of brain changes in the vascular endothelial growth factor family during aging and Alzheimer's disease.
    Seto M; Dumitrescu L; Mahoney ER; Sclafani AM; De Jager PL; Menon V; Koran MEI; Robinson RA; Ruderfer DM; Cox NJ; Seyfried NT; Jefferson AL; Schneider JA; Bennett DA; Petyuk VA; Hohman TJ
    Neurobiol Aging; 2023 Jun; 126():25-33. PubMed ID: 36905877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Continuous Extension of Gene Set Enrichment Analysis Using the Likelihood Ratio Test Statistics Identifies Vascular Endothelial Growth Factor as a Candidate Pathway for Alzheimer's Disease via ITGA5.
    Mahzarnia A; Lutz MW; Badea A
    J Alzheimers Dis; 2024; 97(2):635-648. PubMed ID: 38160360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations Between CSF Markers of Inflammation, White Matter Lesions, and Cognitive Decline in Individuals Without Dementia.
    Gertje EC; Janelidze S; van Westen D; Cullen N; Stomrud E; Palmqvist S; Hansson O; Mattsson-Carlgren N
    Neurology; 2023 Apr; 100(17):e1812-e1824. PubMed ID: 36882326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VEGF Family Gene Expression as Prognostic Biomarkers for Alzheimer's Disease and Primary Liver Cancer.
    Xu K; Wu CL; Wang ZX; Wang HJ; Yin FJ; Li WD; Liu CC; Fan HN
    Comput Math Methods Med; 2021; 2021():3422393. PubMed ID: 34845413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markers of neuroinflammation associated with Alzheimer's disease pathology in older adults.
    Popp J; Oikonomidi A; Tautvydaitė D; Dayon L; Bacher M; Migliavacca E; Henry H; Kirkland R; Severin I; Wojcik J; Bowman GL
    Brain Behav Immun; 2017 May; 62():203-211. PubMed ID: 28161476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional relationships between CSF VEGF levels and Alzheimer's disease brain biomarkers and cognition.
    Tubi MA; Kothapalli D; Hapenney M; Feingold FW; Mack WJ; King KS; Thompson PM; Braskie MN;
    Neurobiol Aging; 2021 Sep; 105():241-251. PubMed ID: 34126466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examining the association between blood-based biomarkers and human post mortem neuropathology in the University of Kentucky Alzheimer's Disease Research Center autopsy cohort.
    Winder Z; Sudduth TL; Anderson S; Patel E; Neltner J; Martin BJ; Snyder KE; Abner EL; Jicha GA; Nelson PT; Wilcock DM
    Alzheimers Dement; 2023 Jan; 19(1):67-78. PubMed ID: 35266629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
    Mandecka M; Budziszewska M; Barczak A; Pepłońska B; Chodakowska-Żebrowska M; Filipek-Gliszczyńska A; Nesteruk M; Styczyńska M; Barcikowska M; Gabryelewicz T
    J Alzheimers Dis; 2016 Jul; 54(1):157-68. PubMed ID: 27472875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.
    Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Li QX; Ames D; Masters CL; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM;
    J Alzheimers Dis; 2018; 66(3):1193-1211. PubMed ID: 30412495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.
    Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W;
    J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral Markers of Vascular Endothelial Dysfunction Show Independent but Additive Relationships with Brain-Based Biomarkers in Association with Functional Impairment in Alzheimer's Disease.
    Drake JD; Chambers AB; Ott BR; Daiello LA;
    J Alzheimers Dis; 2021; 80(4):1553-1565. PubMed ID: 33720880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of 10 VEGF Family Genes with Alzheimer's Disease Endophenotypes at Single Cell Resolution.
    Wu Y; Libby JB; Dumitrescu L; De Jager PL; Menon V; Schneider JA; Bennett DA; Hohman TJ
    bioRxiv; 2024 May; ():. PubMed ID: 38826287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockage of VEGF function by bevacizumab alleviates early-stage cerebrovascular dysfunction and improves cognitive function in a mouse model of Alzheimer's disease.
    Zhang M; Zhang Z; Li H; Xia Y; Xing M; Xiao C; Cai W; Bu L; Li Y; Park TE; Tang Y; Ye X; Lin WJ
    Transl Neurodegener; 2024 Jan; 13(1):1. PubMed ID: 38173017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversing pathology in a preclinical model of Alzheimer's disease by hacking cerebrovascular neoangiogenesis with advanced cancer therapeutics.
    Singh CSB; Choi KB; Munro L; Wang HY; Pfeifer CG; Jefferies WA
    EBioMedicine; 2021 Sep; 71():103503. PubMed ID: 34534764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential effect on molecular pathways in different targeted genes in the VEGF family in retina - From the genomic point of view.
    Cui J; Liu L; Lu H; Wei D; Jiao Y; Jablonski MM; Williams RW; Gu W; Chen H
    Exp Eye Res; 2018 Nov; 176():78-87. PubMed ID: 29944851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VEGFR2 alteration in Alzheimer's disease.
    Cho SJ; Park MH; Han C; Yoon K; Koh YH
    Sci Rep; 2017 Dec; 7(1):17713. PubMed ID: 29255164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum IL-6, sAXL, and YKL-40 as systemic correlates of reduced brain structure and function in Alzheimer's disease: results from the DELCODE study.
    Brosseron F; Maass A; Kleineidam L; Ravichandran KA; Kolbe CC; Wolfsgruber S; Santarelli F; Häsler LM; McManus R; Ising C; Röske S; Peters O; Cosma NC; Schneider LS; Wang X; Priller J; Spruth EJ; Altenstein S; Schneider A; Fliessbach K; Wiltfang J; Schott BH; Buerger K; Janowitz D; Dichgans M; Perneczky R; Rauchmann BS; Teipel S; Kilimann I; Görß D; Laske C; Munk MH; Düzel E; Yakupow R; Dobisch L; Metzger CD; Glanz W; Ewers M; Dechent P; Haynes JD; Scheffler K; Roy N; Rostamzadeh A; Spottke A; Ramirez A; Mengel D; Synofzik M; Jucker M; Latz E; Jessen F; Wagner M; Heneka MT;
    Alzheimers Res Ther; 2023 Jan; 15(1):13. PubMed ID: 36631909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.